RETRACTED ARTICLE: CKS2 induces autophagy-mediated glutathione metabolic reprogramming to facilitate ferroptosis resistance in colon cancer
2024

CKS2 and Ferroptosis Resistance in Colon Cancer

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yang Leilei, Fang Chengfeng, Han Jiaju, Ren Yufeng, Yang Zaiping, Shen Lingyan, Luo Dinghai, Zhang Ruili, Chen Yan, Zhou Shenkang

Primary Institution: Taizhou Hospital, Wenzhou Medical University

Hypothesis

The study investigates the role of CKS2 in modulating ferroptosis resistance in colon cancer cells.

Conclusion

CKS2 suppresses ferroptosis in colon cancer by modulating glutathione metabolism, suggesting it as a potential therapeutic target.

Supporting Evidence

  • CKS2 expression was elevated in colon cancer tissues.
  • Knockdown of CKS2 enhanced ferroptosis in colon cancer cells.
  • CKS2 overexpression reduced ferroptosis sensitivity.
  • CKS2 knockdown increased sorafenib-induced ferroptosis.
  • CKS2 modulated glutathione metabolism in colon cancer cells.

Takeaway

CKS2 is a protein that helps colon cancer cells survive by preventing a type of cell death called ferroptosis, which is important for fighting cancer.

Methodology

The study used bioinformatics, RNA-seq, qRT-PCR, Western blot, and various assays to analyze the effects of CKS2 on colon cancer cells.

Limitations

The study does not explore the role of CKS2 in other forms of ferroptosis induced by different agents.

Participant Demographics

Patients with colon cancer who underwent surgical resection.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s10020-024-00979-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication